CEFTRIAXONE ZENTIVA 1 g/10 ml, powder and solvent for solution for injection (IV) bottle
Active ingredients: Ceftriaxone, Ceftriaxone sodium heptahydrate
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for injectionbottleintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CEFTRIAXONE ZENTIVA 1 g/10 ml, poudre et solvant pour solution injectable (IV)
- Pharmaceutical form
- poudre et solvant pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon(s) en verre - 1 ampoule(s) en verre
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 8 Aug 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61164690CIP73674414CIP133400936744141Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CEFTRIAXONE SODIQUEpoudre | 1079,27 mg · un flacon de poudre | SA |
| CEFTRIAXONE BASEpoudre | 1000 mg · un flacon de poudre | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.